| Revenue | — | — | — |
| Health care services | 15.09a | 15.39a | 15.42a |
| Health care products | 4.25a | 4.06a | 3.98a |
| Revenue | 19.34a | 19.45a | 19.4a |
| Costs of revenue | — | — | — |
| Health care services | -12.16a | -12.18a | -12.24a |
| Health care products | -2.42a | -2.35a | -2.26a |
| Costs of revenue | -14.58a | -14.53a | -14.5a |
| Operating (income) expenses | — | — | — |
| Selling, general and administrative | -3.14a | -3.2a | -3.17a |
| Research and development | -0.18a | -0.23a | -0.23a |
| Income from equity method investees | -0.13a | -0.12a | -0.07a |
| Other operating income | -0.76a | -0.52a | -0.55a |
| Other operating expense | -0.93a | -0.76a | -0.75a |
| Remeasurement gain from Interwell Health | 0a | 0a | -0.15a |
| Operating income | 1.39a | 1.37a | 1.51a |
| Other (income) expense | — | — | — |
| Interest income | -0.07a | -0.09a | -0.07a |
| Interest expense | -0.41a | -0.42a | -0.36a |
| Income before income taxes | 1.06a | 1.03a | 1.22a |
| Income tax expense | -0.32a | -0.3a | -0.32a |
| Net income | 0.74a | 0.73a | 0.89a |
| Net income attributable to noncontrolling interests | 0.2a | 0.23a | 0.22a |
| Net income attributable to shareholders of FME AG | 0.54a | 0.5a | 0.67a |